<?xml version="1.0" encoding="utf-8"?>
<oai_dcterms:dcterms xmlns:oai_dcterms="http://www.openarchives.org/OAI/2.0/oai_dcterms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tei="http://www.tei-c.org/ns/1.0">
  <dcterms:identifier>adm-01859221</dcterms:identifier>
  <dcterms:identifier>https://www.documentation-administrative.gouv.fr/adm-01859221</dcterms:identifier>
  <dcterms:identifier>https://www.documentation-administrative.gouv.fr/adm-01859221v1/document</dcterms:identifier>
  <dcterms:identifier>https://www.documentation-administrative.gouv.fr/adm-01859221v1/file/avis_conseil_scientifique_16_avril_2021.pdf</dcterms:identifier>
  <dcterms:title xml:lang="fr">Coronavirus COVID-19 : avis du Conseil scientifique constitué au titre de l'état d'urgence sanitaire (16 avril 2021). Le variant "brésilien" P1 : anticiper pour l'été</dcterms:title>
  <dcterms:creator>Conseil scientifique COVID-19, (collectif)</dcterms:creator>
  <dcterms:subject>[SPM.SOCIAL] /Santé - Social - Handicap</dcterms:subject>
  <dcterms:subject>[SPM.INTERNATIONAL] /International - Europe - Francophonie</dcterms:subject>
  <dcterms:type>AVIS_NOTE</dcterms:type>
  <dcterms:subject xml:lang="fr">Brésil</dcterms:subject>
  <dcterms:subject xml:lang="fr">B.1.351</dcterms:subject>
  <dcterms:subject xml:lang="fr">Protéine S</dcterms:subject>
  <dcterms:subject xml:lang="fr">Spike</dcterms:subject>
  <dcterms:subject xml:lang="fr">Variant californien</dcterms:subject>
  <dcterms:subject xml:lang="fr">BR-P1</dcterms:subject>
  <dcterms:subject xml:lang="fr">BR-P2</dcterms:subject>
  <dcterms:subject xml:lang="fr">Variants brésiliens</dcterms:subject>
  <dcterms:subject xml:lang="fr">Gestes barrière</dcterms:subject>
  <dcterms:subject xml:lang="fr">Lignage</dcterms:subject>
  <dcterms:subject xml:lang="fr">Variant sud-africain</dcterms:subject>
  <dcterms:subject xml:lang="fr">B.1.1.7</dcterms:subject>
  <dcterms:subject xml:lang="fr">Protocoles sanitaires</dcterms:subject>
  <dcterms:subject xml:lang="fr">Manaus</dcterms:subject>
  <dcterms:subject xml:lang="fr">ACE2</dcterms:subject>
  <dcterms:subject xml:lang="fr">Anticorps</dcterms:subject>
  <dcterms:subject xml:lang="fr">Guyane</dcterms:subject>
  <dcterms:subject xml:lang="fr">Italie</dcterms:subject>
  <dcterms:subject xml:lang="fr">Canada</dcterms:subject>
  <dcterms:subject xml:lang="fr">Anticorps monoclonaux</dcterms:subject>
  <dcterms:subject xml:lang="fr">Immunité</dcterms:subject>
  <dcterms:subject xml:lang="fr">Criblage</dcterms:subject>
  <dcterms:subject xml:lang="fr">Suriname</dcterms:subject>
  <dcterms:subject xml:lang="fr">Vaccin ARNm</dcterms:subject>
  <dcterms:subject xml:lang="fr">Situation sanitaire</dcterms:subject>
  <dcterms:subject xml:lang="fr">Récepteur cellulaire</dcterms:subject>
  <dcterms:subject xml:lang="fr">Chili</dcterms:subject>
  <dcterms:subject xml:lang="fr">Échappement immunitaire</dcterms:subject>
  <dcterms:subject xml:lang="fr">B.1.427</dcterms:subject>
  <dcterms:subject xml:lang="fr">COVID-19</dcterms:subject>
  <dcterms:subject xml:lang="fr">Transmissibilité</dcterms:subject>
  <dcterms:subject xml:lang="fr">SARS-CoV-2</dcterms:subject>
  <dcterms:subject xml:lang="fr">Infections respiratoires</dcterms:subject>
  <dcterms:subject xml:lang="fr">Coronavirus</dcterms:subject>
  <dcterms:subject xml:lang="fr">Infection</dcterms:subject>
  <dcterms:subject xml:lang="fr">Épidémie</dcterms:subject>
  <dcterms:subject xml:lang="fr">Pandémie</dcterms:subject>
  <dcterms:subject xml:lang="fr">Urgences</dcterms:subject>
  <dcterms:subject xml:lang="fr">Libre circulation</dcterms:subject>
  <dcterms:subject xml:lang="fr">Amérique du Sud</dcterms:subject>
  <dcterms:subject xml:lang="fr">Propagation</dcterms:subject>
  <dcterms:subject xml:lang="fr">Contamination</dcterms:subject>
  <dcterms:subject xml:lang="fr">Patients</dcterms:subject>
  <dcterms:subject xml:lang="fr">Dispositif de surveillance</dcterms:subject>
  <dcterms:subject xml:lang="fr">Déplacements</dcterms:subject>
  <dcterms:subject xml:lang="fr">Circulation virale</dcterms:subject>
  <dcterms:subject xml:lang="fr">Variants</dcterms:subject>
  <dcterms:subject xml:lang="fr">Vague</dcterms:subject>
  <dcterms:subject xml:lang="fr">Système de soins</dcterms:subject>
  <dcterms:subject xml:lang="fr">Contexte sanitaire</dcterms:subject>
  <dcterms:subject xml:lang="fr">Indicateurs sanitaires</dcterms:subject>
  <dcterms:subject xml:lang="fr">Pression hospitalière</dcterms:subject>
  <dcterms:subject xml:lang="fr">Variant anglais</dcterms:subject>
  <dcterms:subject xml:lang="fr">Reprise épidémique</dcterms:subject>
  <dcterms:abstract xml:lang="fr">
              Dans son avis du 16 avril 2021, le Conseil scientifique fait le point sur le variant "brésilien" P1 et émet plusieurs préconisations, pour "anticiper pour l'été", en France métropolitaine et en Guyane.
            </dcterms:abstract>
  <dcterms:created>2021-04-16</dcterms:created>
  <dcterms:available>2021-05-18</dcterms:available>
  <dcterms:language>fr</dcterms:language>
  <dcterms:licence xsi:type="dcterms:URI">https://www.etalab.gouv.fr/wp-content/uploads/2017/04/ETALAB-Licence-Ouverte-v2.0.pdf</dcterms:licence>
</oai_dcterms:dcterms>
